Advertisement
HROW vs TLPH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HROW is a Buy and TLPH is a Hold.
HROW in +2.02% Uptrend, advancing for three consecutive days on October 21, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where HROW advanced for three days, in 240 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HROW's RSI Indicator exited the oversold zone, 31 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for HROW just turned positive on October 20, 2026. Looking at past instances where HROW's MACD turned positive, the stock continued to rise in 36 of 47 cases over the following month. The odds of a continued upward trend are 77%.
HROW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HROW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
The Aroon Indicator for HROW entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. HROW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (69.427) is normal, around the industry mean (10.407). P/E Ratio (-28.434) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (0.270) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (4.627) is also within normal values, averaging (178.797).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
TLPH's RSI Indicator recovers from oversold territory
The RSI Indicator for TLPH moved out of oversold territory on October 08, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In 24 of the 26 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for TLPH just turned positive on October 20, 2026. Looking at past instances where TLPH's MACD turned positive, the stock continued to rise in 42 of 46 cases over the following month. The odds of a continued upward trend are 90%.
Following a +1.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where TLPH advanced for three days, in 179 of 223 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
TLPH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TLPH as a result. In 80 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TLPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for TLPH entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. TLPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.783) is normal, around the industry mean (10.407). P/E Ratio (-4.565) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (1250.000) is also within normal values, averaging (178.797).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TLPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
HROW | TLPH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 3 | 41 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 84 Overvalued | 93 Overvalued | |
PROFIT vs RISK RATING 1..100 | 65 | 100 | |
SMR RATING 1..100 | 99 | 99 | |
PRICE GROWTH RATING 1..100 | 81 | 58 | |
P/E GROWTH RATING 1..100 | 14 | 21 | |
SEASONALITY SCORE 1..100 | 85 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HROW's Valuation (84) in the Pharmaceuticals Other industry is in the same range as TLPH (93). This means that HROW’s stock grew similarly to TLPH’s over the last 12 months.
HROW's Profit vs Risk Rating (65) in the Pharmaceuticals Other industry is somewhat better than the same rating for TLPH (100). This means that HROW’s stock grew somewhat faster than TLPH’s over the last 12 months.
HROW's SMR Rating (99) in the Pharmaceuticals Other industry is in the same range as TLPH (99). This means that HROW’s stock grew similarly to TLPH’s over the last 12 months.
TLPH's Price Growth Rating (58) in the Pharmaceuticals Other industry is in the same range as HROW (81). This means that TLPH’s stock grew similarly to HROW’s over the last 12 months.
HROW's P/E Growth Rating (14) in the Pharmaceuticals Other industry is in the same range as TLPH (21). This means that HROW’s stock grew similarly to TLPH’s over the last 12 months.
| HROW | TLPH | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 74% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 80% | 1 day ago 89% |
| Momentum ODDS (%) | N/A | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 77% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 82% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 83% | 1 day ago 90% |
| Advances ODDS (%) | 2 days ago 82% | 7 days ago 80% |
| Declines ODDS (%) | 9 days ago 79% | 9 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 72% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 84% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HROW’s FA Score shows that 1 FA rating(s) are green while TLPH’s FA Score has 1 green FA rating(s).
- HROW’s FA Score: 1 green, 4 red.
- TLPH’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HROW’s TA Score shows that 5 TA indicator(s) are bullish while TLPH’s TA Score has 6 bullish TA indicator(s).
- HROW’s TA Score: 5 bullish, 2 bearish.
- TLPH’s TA Score: 6 bullish, 2 bearish.
Price Growth
HROW (@Pharmaceuticals: Generic) experienced а +3.67% price change this week, while TLPH (@Pharmaceuticals: Generic) price change was +0.94% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -2.94%. For the same industry, the average monthly price growth was -9.84%, and the average quarterly price growth was +9.53%.
Reported Earning Dates
HROW is expected to report earnings on Nov 09, 2026.
TLPH is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-2.94% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
HROW and
Correlation & Price change
A.I.dvisor indicates that over the last year, HROW has been loosely correlated with AQST. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then AQST could also see price increases.
| Ticker / NAME | Correlation To HROW | 1D Price Change % | ||
|---|---|---|---|---|
| HROW | 100% | -0.32% | ||
| AQST - HROW | 35% Loosely correlated | +1.23% | ||
| AMRX - HROW | 30% Poorly correlated | +1.39% | ||
| AYTU - HROW | 28% Poorly correlated | +1.02% | ||
| RMTI - HROW | 27% Poorly correlated | -0.28% | ||
| TEVA - HROW | 27% Poorly correlated | -1.01% | ||
More | ||||
TLPH and
Correlation & Price change
A.I.dvisor tells us that TLPH and TKNO have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPH and TKNO's prices will move in lockstep.
| Ticker / NAME | Correlation To TLPH | 1D Price Change % | ||
|---|---|---|---|---|
| TLPH | 100% | -1.87% | ||
| TKNO - TLPH | 24% Poorly correlated | +5.13% | ||
| HROW - TLPH | 24% Poorly correlated | -0.32% | ||
| AYTU - TLPH | 23% Poorly correlated | +1.02% | ||
| TXMD - TLPH | 21% Poorly correlated | -2.63% | ||
| ZSTK - TLPH | 21% Poorly correlated | -5.88% | ||
More | ||||